Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
SensiCardiac is a digital health and medical device business focused on AI-assisted cardiac auscultation and heart murmur screening. The company developed FDA 510(k)-cleared software that works with electronic stethoscopes to record, analyze, classify, and share heart sounds, helping clinicians distinguish pathological from functional or physiological murmurs. Its technology appears to have evolved from the original Sensi/SensiCardiac software developed by Diacoustic Medical Devices in South Africa into the current cloud-based TeleSensi Cardiac offering. The broader platform also supports live diagnostic-quality stethoscope streaming for telehealth workflows, particularly in primary care, rural care, and cardiology support settings. The company is not a therapeutics developer; it operates in medtech/software rather than biotech or pharma.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on SensiCardiac.